SCHEMBL19291073

SCHEMBL19291073

CCC(=O)N1CC[C@H](C)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
LMNA P02545 1/20 0.55
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
POLB P06746 1/20 0.54
MAPT P10636 1/20 0.54
NPC1 O15118 1/20 0.52
CHRNB2 P17787 3/20 0.47
CHRNA3 P32297 3/20 0.47
CHRNA4 P43681 3/20 0.47
CHRNB3 Q05901 1/20 0.47
CHRNA6 Q15825 1/20 0.47
EPHX2 P34913 3/20 0.46
CHRNB4 P30926 2/20 0.46
CHRNA7 P36544 2/20 0.46
DPP4 P27487 1/20 0.43
DPP8 Q6V1X1 1/20 0.43
DPP7 Q9UHL4 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HPGD P15428 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13727214 1.00 ALDH1A1 (0.55) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL16621832 1.00 ALDH1A1 (0.55) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL478307 0.88 ALDH1A1 (0.71) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL22474755 0.88 ALDH1A1 (0.71) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL15014489 0.88 ALDH1A1 (0.71) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL10282539 0.87 ALDH1A1 (0.67) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL19240755 0.86 ALDH1A1 (0.64) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL19528315 0.84 MEN1 (0.65) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL10274495 0.84 MEN1 (0.65) ALDH1A1LMNAMEN1KMT2APOLB
SCHEMBL24456999 0.83 ALDH1A1 (0.55) ALDH1A1LMNAMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3210971-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2017-08-30 EP disclosed